8
Total deals
$6.1B
Total value
$1.2B
Avg deal
$4.8B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Amicus Therapeutics
Amicus Therapeutics is a biotechnology company that discovers, develops, and com…
|
2025-12-19 | Acquisition | Complete | $4.8B | Deal → |
| 2 |
Inozyme
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases…
|
2025-05-16 | Merge | Complete | $270.0M | Deal → |
| 3 |
Prosensa
Prosensa provides RNA-based therapeutics for the treatment of genetic disorders,…
|
2014-11-24 | Acquisition | Complete | $840.0M | Deal → |
| 4 |
Zacharon Pharmaceuticals
Zacharon Pharmaceuticals employs its glycobiology expertise to develop a new cla…
|
2013-01-07 | Acquisition | Complete | — | Deal → |
| 5 |
Zystor
ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing e…
|
2010-08-17 | Acquisition | Complete | $115.0M | Deal → |
| 6 |
LEAD Therapeutics
LEAD Therapeutics is a drug discovery company developing small molecule IND cand…
|
2010-02-10 | Acquisition | Complete | $97.0M | Deal → |
| 7 |
H
Huxley Pharmaceuticals
Huxley Pharmaceuticals is private life sciences company founded and managed by A…
|
2009-10-26 | Acquisition | Complete | — | Deal → |
| 8 |
G
Glyko Biomedical
Glyko Biomedical Ltd. offers scientific research services aimed at developing no…
|
2002-02-07 | Acquisition | Complete | — | Deal → |